Human immunodeficiency virus 2 (HIV-2) infection is characterized by a slower disease progression and lower transmission rates. The molecular features that could be assigned as directly involved in this in vivo phenotype remain essentially unknown, and th. - Fundacao para a Ciencia e Tecnologia (FCT) [POCI/SAU-IMI/55726/2004]. - Grant sponsor: Fundacao para a Ciencia e Tecnologia (FCT); Grant number: POCI/SAU-IMI/55726/2004
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are both causative agents of AIDS, wi...
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated f...
Human immunodeficiency virus 2 (HIV-2) infection is characterized by a slower disease progression an...
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properti...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) differ in their pathogenic mechanisms...
AbstractThe chemokine coreceptors play a significant role in HIV entry and pathogenesis. The V3 regi...
HIV-2 is less pathogenic and less transmissible compared to HIV-1. This is believed to be due to the...
Human immunodeficiency virus type 2 (HIV-2) infections cause severe immunodeficiency in humans, alth...
We have previously shown the existence of primary human immunodeficiency virus type 2 isolates (MIC9...
Abstract publicado em: International Journal of Infectious Diseases. 2010;14(Supl 1).Background: Hu...
The objective of the study was to assess the genotypic and phenotypic properties of 18 viral strains...
HIV has killed millions of people since its discovery in the 1980s and continues to be a costly dise...
© 2006, American Society for Microbiology. All Rights Reserved.CCR5 expression determines susceptibi...
Background: The HIV-2 env’s 3 ’ end encodes the cytoplasmic tail (CT) of the Env protein. This genom...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are both causative agents of AIDS, wi...
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated f...
Human immunodeficiency virus 2 (HIV-2) infection is characterized by a slower disease progression an...
Limited data are available on the pathogenesis of HIV-2, and the evolution of Env molecular properti...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) differ in their pathogenic mechanisms...
AbstractThe chemokine coreceptors play a significant role in HIV entry and pathogenesis. The V3 regi...
HIV-2 is less pathogenic and less transmissible compared to HIV-1. This is believed to be due to the...
Human immunodeficiency virus type 2 (HIV-2) infections cause severe immunodeficiency in humans, alth...
We have previously shown the existence of primary human immunodeficiency virus type 2 isolates (MIC9...
Abstract publicado em: International Journal of Infectious Diseases. 2010;14(Supl 1).Background: Hu...
The objective of the study was to assess the genotypic and phenotypic properties of 18 viral strains...
HIV has killed millions of people since its discovery in the 1980s and continues to be a costly dise...
© 2006, American Society for Microbiology. All Rights Reserved.CCR5 expression determines susceptibi...
Background: The HIV-2 env’s 3 ’ end encodes the cytoplasmic tail (CT) of the Env protein. This genom...
Understanding human immunodeficiency virus type 1 (HIV-1) transmission is central to developing effe...
Human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) are both causative agents of AIDS, wi...
We characterized human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Env) isolated f...